Remove Compounding Remove Dosage Remove Presentation
article thumbnail

STAT+: Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more

STAT

Food and Drug Administration wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies that have fueled widespread use of the knockoffs have other plans , The Wall Street Journal writes. And some pharmacies making the GLP-1 drug copycats will continue.

article thumbnail

NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData

Express Pharma

GlobalDatas report, Endometriosis Market Size and Trend Report, reveals that the endometriosis market size across the seven major markets* (7MM) is expected to achieve a compound annual growth rate of more than 9 per cent during 2020-2030.

Dosage 66
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ACMT Toxicology Visual Pearl: Who Doesn’t Like a Nice Rosé?

ALiEM - Pharm Pearls

What clinical presentation and medication is associated with this urinary discoloration?  Deferoxamine binds with ferric iron (Fe3+) to form ferrioxamine, a water-soluble compound excreted in the urine. As Iron toxicity treated with deferoxamine Background Deferoxamine is the treatment for severe iron toxicity [1]. Deferoxamine

article thumbnail

Only 2 per cent medicines undergo quality control checks: Former IMA President

Express Pharma

Presently, over 50% of prescriptions issued by physicians are for fixed dosage combinations spanning various therapeutic categories. Thus, prescribing such medicines using generic names might pose challenges for RMPs, compounded by the difficulty chemists may face in dispensing such prescriptions.

article thumbnail

Enforcement Trends: CDER Presentation Confirms Fewer Warning Letters Are Issued by FDA for OAI Inspections

FDA Law Blog: Biosimilars

Farquhar — At the GMP by the Sea Conference ongoing in Cambridge, Maryland, a presentation was made by a representative of FDA’s Center for Drug Evaluation and Research that shows some interesting trends in enforcement. By Douglas B. OAI is FDA’s classification for facilities it deems to be in an unacceptable state of compliance.

Dosage 52
article thumbnail

Researchers from Queen’s University Belfast develop 3D printed bandage to treat diabetic foot ulcers

Express Pharma

Queen’s University Belfast has designed a new 3D printed bandage which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs). Medical professionals also do not need to change the drug dosage as this double release, supports that need.”

article thumbnail

Advanced Biodesign starts first-in-human clinical trial targeting AML

European Pharmaceutical Review

ABD-3001 is the pharmaceutical form of DIMATE, which targets and inhibits a detoxification system present in cancer cells. DIMATE poisons and kills cancer cells, without harming healthy cells. The ODYSSEY study is organised according to an adaptive design.

Dosage 98